van der Giet Markus
Medizinische Klinik für Nephrologie und Internistische Intensivmedizin, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
Inn Med (Heidelb). 2023 Mar;64(3):234-239. doi: 10.1007/s00108-023-01483-4. Epub 2023 Jan 31.
Well-controlled blood pressure is an essential factor in inhibiting the progression of renal failure and also in controlling cardiovascular mortality and morbidity. For decades there has been an intensive search for the optimal blood pressure target values in order to reduce the progression of renal insufficiency to a physiological level as far as possible. In the last few decades, very different target blood pressure values have been defined, which time and again contribute more to confusion than clarity in everyday clinical practice. The present work considers the relevant guidelines; it analyzes the basis on which the sometimes widely varying guidelines were created. All guidelines agree that blood pressure control with a target of less than 140 mm Hg systolic should be achieved in patients with impaired renal function. The European guidelines recommend aiming for a target of 130-140 mm Hg systolic. The American guidelines go one step further and specify a systolic blood pressure target of less than 130 mm Hg. The Kidney Disease: Improving Global Outcomes (KDIGO) organization is even more ambitious. It recommends a blood pressure target of less than 120 mm Hg, whereby in contrast to the European and American guidelines, the level of evidence required in the guidelines is considered to be very weak and the goals should also be achieved if automated, standardized blood pressure measurement is carried out, which is rarely available in everyday practice and may not be feasible. The present overview discusses the arguments for lowering blood pressure with different goals and presents the evidence. Of course, the blood pressure goals in the presence or absence of albuminuria should also be considered.
血压得到良好控制是抑制肾衰竭进展以及控制心血管疾病死亡率和发病率的关键因素。几十年来,人们一直在深入探寻最佳血压目标值,以便尽可能将肾功能不全的进展降低到生理水平。在过去几十年里,定义了非常不同的目标血压值,这在日常临床实践中一次次造成更多困惑而非清晰明了。本研究考虑了相关指南;分析了有时差异很大的指南制定的依据。所有指南都一致认为,肾功能受损患者应将收缩压控制在低于140 mmHg的目标。欧洲指南建议将收缩压目标设定为130 - 140 mmHg。美国指南更进一步,将收缩压目标明确为低于130 mmHg。改善全球肾脏病预后组织(KDIGO)的目标更为激进。它建议血压目标低于120 mmHg,然而与欧洲和美国指南不同的是,该指南所需的证据水平被认为非常薄弱,而且如果采用自动、标准化血压测量来实现目标,而这在日常实践中很少具备且可能不可行。本综述讨论了设定不同血压降低目标的依据并给出了证据。当然,有无蛋白尿情况下的血压目标也应予以考虑。